TrialForge Inc.

TrialForge Inc. — A single deduplicated, classified corpus of 740,000-plus clinical trials built by merging multiple national and regional registries — including deliberately deep China CDE/NMPA coverage that Western incumbents treat thinly — and refreshed daily. Beyond raw consolidation the vendor performs labelling and enrichment: records are mapped to real ontologies rather than left as free-text registry strings, every value stays source-traceable to its originating registry record, and the corpus is exposed both as an in-platform analytics dataset and as an API/data feed. The asset is th…

TrialForge Inc. offers (Alternative, Fundamental, Reference) — 740,000-plus deduplicated trial records merged from multiple registries and refreshed daily. That deduplicated count exceeds any single national registry, confirming genuine multi-registry consolidation rather than a ClinicalTrials.gov mirror. The specific registry list, per-record field counts and retained snapshot history are not published on the captured pages and should be confirmed against a sample..

Competitive-intelligence monitoring of every rival programme in one place; business-development search and evaluation of assets and biotechs for licensing and M&A; private-equity and investment-banking diligence grounded in the full pipeline landscape; R&D and clinical benchmarking of a sponsor's own programmes against the field; indication sizing and new-product planning; and — because conditions, drugs and targets are ontology-mapped rather than raw strings — a clean labelled corpus for training or validating internal models on trial-landscape data, with China-origin assets included rather than missing from the training set

Coverage spans US, China/HK, UK, Other; Health Care Technology, Pharmaceuticals; alternative, fundamental, reference; equities.